Paid any amount for retail purchases of Pfizer-brand Chantix (varenicline) in the United States and its territories from September 29, 2015 through September 17, 2021.
Payout up to
$300
Deadline
September 14, 2026
Proof required
No
Paid any amount for retail purchases of Pfizer-brand Chantix (varenicline) in the United States and its territories from September 29, 2015 through September 17, 2021. In re Chantix (Varenicline) Mktg., Sales Pracs. & Prods. Liab. Litig. (No. II), 22-MD-3050 (KPF), 22-MC-3050 (S.D.N.Y.). Consumers who paid out-of-pocket for Chantix during the Class Period (including copayments, coinsurance, or deductibles) may submit a claim for a pro rata cash payment from the consumer portion of the $44 million Settlement Fund, capped so that no consumer receives more than the amount they paid for Chantix (estimated up to $300). No documentation required at filing, but the Settlement Administrator may request proof later. Submit online or by mail postmarked by September 14, 2026. Payments are digitally sent by email unless you request an alternative.
No proof of purchase required
Paid any amount for retail purchases of Pfizer-brand Chantix (varenicline) in the United States and its territories from September 29, 2015 through September 17, 2021.
Eligible claimants may receive up to $300 from this settlement. The actual amount may vary based on the number of valid claims submitted.
The deadline to submit your claim is September 14, 2026.
No, this is a no-proof-required settlement. You can file your claim without receipts or proof of purchase.
Sparrow makes it easy — just create an account, select the Chantix (Pfizer-brand) settlement, and we'll pre-fill the claim form for you. The entire process takes about 2 minutes. Sparrow membership is $7 per month (billed at $84 per year) and includes access to all available settlements.